GRIFOLS | GRF - Selling And Administration Expenses

Stock Price
9.22
Daily Change
-0.06 -0.67%
Monthly
-16.50%
Yearly
-3.03%
Q1 Forecast
8.95

GRIFOLS reported EUR275.3M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alcon AG USD 901M 36M Dec/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 17.94M 17.86M Sep/2025
argenx SE USD 429.62M 93.32M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Cie Automotive EUR 315.66M 28.06M Dec/2024
Demant DKK 6.09B 135M Dec/2025
Ence Energia y Celulosa EUR 29.1M 2M Sep/2024
Essilor EUR 5.62B 4.53B Dec/2025
Ferrovial EUR 906M 52M Dec/2024
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Galapagos EUR 44.42M 9.87M Dec/2025
Genmab DKK 144M 18M Jun/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 275.3M 9.7M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Inditex EUR 2.51B 7.98B Jan/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
UCB EUR 1.29B 221M Dec/2024
Viscofan EUR 72.59M 4.52M Mar/2025